CNS therapeutics firm Sage nets $549mm in FOPO

14:41 EST 14 Feb 2018 | Elsevier Business Intelligence

CNS-focused Sage Therapeutics Inc. netted $549mm in a follow-on offering of 3.5mm shares at $164. The company will use the pr...

Original Article: CNS therapeutics firm Sage nets $549mm in FOPO


More From BioPortfolio on "CNS therapeutics firm Sage nets $549mm in FOPO"

Quick Search


Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...